{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:51:42Z","timestamp":1790167902905,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Shahid Beheshti University of Medical Sciences, Tehran, Iran","award":["28709"],"award-info":[{"award-number":["28709"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What is the global, regional and national burden of polycystic ovary syndrome (PCOS), by age and socio-demographic index (SDI), over the period 1990\u20132019?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>In 2019, the global age-standardized point prevalence, incidence and years lived with disability (YLD) of PCOS were 30.4, 29.5 and 29.9 per 100\u200a000 population, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Data from the Global Burden of Disease (GBD) study 2017 showed that the global age-standardized PCOS incidence rate increased 1.45% over the period 1990\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>A systematic analysis of the PCOS prevalence, incidence and YLDs across 204 countries and territories was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Data on the point prevalence, annual incidence and YLDs due to PCOS were retrieved from the GBD study 2019 for 204 countries and territories from 1990 to 2019. The counts and age-standardized rates (per 100\u200a000) are presented, along with their corresponding 95% uncertainty intervals (UIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>In 2019, the global age-standardized point prevalence and annual incidence rates for PCOS were 1677.8 (95% UI: 1166.0 to 2192.4) and 59.8 (95% UI: 41.7 to 78.9) per 100\u200a000, which represents a 30.4% and 29.5% increase since 1990, respectively. Moreover, the global age-standardized YLD rate in 2019 was 14.7 (6.3\u201329.5), an increase of 29.9% since 1990. In 2019, Italy (7897.0), Japan (6298.7) and New Zealand (5419.1) had the highest estimated age-standardized point prevalences of PCOS. Globally, the number of prevalent cases and the point prevalence of PCOS peaked in the 25\u201329\u2009years and 40\u201344\u2009years age groups, respectively. Positive associations were found between the burden of PCOS and the SDI at the regional and national levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>Variations in how PCOS was defined is a major limitation that prevents valid comparisons between different regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Globally, the burden of PCOS has increased at an alarming rate, making it a major public health concern. Increasing public awareness about this common condition, improving management options and increasing support to reduce factors which lead to further complications, need to be public health priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>The Bill and Melinda Gates Foundation, who were not involved in any way in the preparation of this manuscript, funded the GBD study. The Shahid Beheshti University of Medical Sciences, Tehran, Iran (Grant No. 28709) also supported the present report. The authors declare no competing interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deac091","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T07:17:08Z","timestamp":1650439028000},"page":"1919-1931","source":"Crossref","is-referenced-by-count":108,"title":["Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-9072","authenticated-orcid":false,"given":"Saeid","family":"Safiri","sequence":"first","affiliation":[{"name":"Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences , Tabriz, Iran"},{"name":"Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences , Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Noori","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Iran University of Medical Sciences , Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"additional","affiliation":[{"name":"Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences , Tabriz, Iran"},{"name":"School of Medicine, Shahid Beheshti University of Medical Sciences , Tehran, Iran"},{"name":"Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN) , Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Karamzad","sequence":"additional","affiliation":[{"name":"Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences , Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Carson-Chahhoud","sequence":"additional","affiliation":[{"name":"Australian Centre for Precision Health, Allied Health and Human Performance, University of South Australia , South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J M","family":"Sullman","sequence":"additional","affiliation":[{"name":"Department of Life and Health Sciences, University of Nicosia , Nicosia, Cyprus"},{"name":"Department of Social Sciences, University of Nicosia , Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-2316","authenticated-orcid":false,"given":"Gary S","family":"Collins","sequence":"additional","affiliation":[{"name":"Centre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford , Oxford, UK"},{"name":"NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust , Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-3732","authenticated-orcid":false,"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[{"name":"Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences , Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8857-9162","authenticated-orcid":false,"given":"Jodie","family":"Avery","sequence":"additional","affiliation":[{"name":"Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia \u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"2022080105595815200_deac091-B2","first-page":"230","article-title":"Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome","volume":"2","author":"Alur-Gupta","year":"2021","journal-title":"F S Rep"},{"key":"2022080105595815200_deac091-B3","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"Polycystic ovary syndrome, ACOG practice bulletin no. 194","volume":"131","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Gynecology","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2022080105595815200_deac091-B4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0015-0282(03)00502-8","article-title":"Familial associations in women with polycystic ovary syndrome","volume":"80","author":"Atiomo","year":"2003","journal-title":"Fertil Steril"},{"key":"2022080105595815200_deac091-B5","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2022080105595815200_deac091-B6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2022080105595815200_deac091-B7","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2022080105595815200_deac091-B8","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"2022080105595815200_deac091-B9","first-page":"1","article-title":"Association between dietary patterns and precocious puberty in children: a population-based study","volume":"2018","author":"Chen","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2022080105595815200_deac091-B10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09513590312331290268","article-title":"The effect of polycystic ovary syndrome on health-related quality of life","volume":"17","author":"Coffey","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"2022080105595815200_deac091-B11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/09513590.2021.1871892","article-title":"IMPROVE lifestyle in polycystic ovary syndrome: a systematic strategy","volume":"37","author":"Del Pup","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"2022080105595815200_deac091-B12","doi-asserted-by":"crossref","first-page":"e012461","DOI":"10.1136\/bmjopen-2016-012461","article-title":"Diagnosis and management of polycystic ovary syndrome in the UK (2004\u20132014): a retrospective cohort study","volume":"6","author":"Ding","year":"2016","journal-title":"BMJ Open"},{"key":"2022080105595815200_deac091-B13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/humrep\/dey093","article-title":"Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study","volume":"33","author":"Ding","year":"2018","journal-title":"Hum Reprod"},{"key":"2022080105595815200_deac091-B14","doi-asserted-by":"crossref","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"2022080105595815200_deac091-B15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpag.2011.11.009","article-title":"Exercise and sedentary habits among adolescents with PCOS","volume":"25","author":"Eleftheriadou","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2022080105595815200_deac091-B17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/jcm8101606","article-title":"The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies","volume":"8","author":"Hiam","year":"2019","journal-title":"J Clin Med"},{"key":"2022080105595815200_deac091-B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Womens Health"},{"key":"2022080105595815200_deac091-B19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.21037\/tp.2017.09.11","article-title":"Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies","volume":"6","author":"Kamboj","year":"2017","journal-title":"Transl Pediatr"},{"key":"2022080105595815200_deac091-B20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"2022080105595815200_deac091-B21","doi-asserted-by":"crossref","first-page":"e0123608","DOI":"10.1371\/journal.pone.0123608","article-title":"Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women","volume":"10","author":"Khomami","year":"2015","journal-title":"PLoS One"},{"key":"2022080105595815200_deac091-B22","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/DMSO.S216791","article-title":"How western diet and lifestyle drive the pandemic of obesity and civilization diseases","volume":"12","author":"Kopp","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2022080105595815200_deac091-B23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.fertnstert.2019.05.021","article-title":"Changes in diet composition with urbanization and its effect on the polycystic ovarian syndrome phenotype in a Western Indian population","volume":"112","author":"Kulkarni","year":"2019","journal-title":"Fertil Steril"},{"key":"2022080105595815200_deac091-B24","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2022080105595815200_deac091-B25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","article-title":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017","volume":"36","author":"Liu","year":"2021","journal-title":"Hum Reprod"},{"key":"2022080105595815200_deac091-B27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5114\/aoms.2019.87112","article-title":"National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016","volume":"17","author":"Miazgowski","year":"2021","journal-title":"Arch Med Sci"},{"key":"2022080105595815200_deac091-B28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10815-009-9297-7","article-title":"Familial associations between polycystic ovarian syndrome and common diseases","volume":"26","author":"Moini","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"2022080105595815200_deac091-B29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijgo.12824","article-title":"Prevalence of polycystic ovary syndrome in a metabolically healthy obese population","volume":"146","author":"Mu","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"2022080105595815200_deac091-B30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"2022080105595815200_deac091-B31","first-page":"533","article-title":"The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis","volume":"17","author":"Naz","year":"2019","journal-title":"Int J Reprod Biomed"},{"key":"2022080105595815200_deac091-B33","first-page":"299.e1\u20137","article-title":"Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2022080105595815200_deac091-B34","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/EC-18-0502","article-title":"Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus","volume":"8","author":"Rodgers","year":"2019","journal-title":"Endocr Connect"},{"key":"2022080105595815200_deac091-B36","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022080105595815200_deac091-B37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2022080105595815200_deac091-B38","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob Health"},{"key":"2022080105595815200_deac091-B39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12955-020-01484-z","article-title":"Health-related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: a case-control study","volume":"18","author":"S\u00e1nchez-Ferrer","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2022080105595815200_deac091-B40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.reprotox.2021.06.005","article-title":"Potential environmental toxicant exposure, metabolizing gene variants and risk of PCOS\u2014a systematic review","volume":"103","author":"Sharma","year":"2021","journal-title":"Reprod Toxicol"},{"key":"2022080105595815200_deac091-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2022080105595815200_deac091-B42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2022080105595815200_deac091-B43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/CLEP.S311785","article-title":"Genetically predicted cigarette smoking in relation to risk of polycystic ovary syndrome","volume":"13","author":"Tao","year":"2021","journal-title":"Clin Epidemiol"},{"key":"2022080105595815200_deac091-B44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"2022080105595815200_deac091-B45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"2022080105595815200_deac091-B46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","article-title":"New perspectives on the pathogenesis of PCOS: neuroendocrine origins","volume":"29","author":"Walters","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"2022080105595815200_deac091-B47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","volume":"83","author":"Witchel","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"2022080105595815200_deac091-B48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41390-019-0615-1","article-title":"Curtailing PCOS","volume":"87","author":"Witchel","year":"2020","journal-title":"Pediatr Res"},{"key":"2022080105595815200_deac091-B49","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijerph15112589","article-title":"Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity","volume":"15","author":"Wolf","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2022080105595815200_deac091-B50","first-page":"377","author":"Zawadzki","year":"1992"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/8\/1919\/45197895\/deac091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/8\/1919\/45197895\/deac091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T02:02:56Z","timestamp":1659319376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/8\/1919\/6588472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,5,19]]},"published-print":{"date-parts":[[2022,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac091","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,5,19]]}}}